Join the Oncology Voice Network. Join for Free
Digital Therapeutics: Everything You Need to Know
Digital Therapeutics Medical Science Liaison COVID-19 technology adaptation opportunities in tech for MSLs future of Digital Therapeutics

Digital Therapeutics: Everything You Need to Know


Share This Article


Summary

In this episode, Tom Caravela welcomes Madleine Makori to discuss her career journey and passion for the MSL role, with a particular focus on digital therapeutics. Madleine shares insights into the differentiation and challenges of digital therapeutics and how COVID-19 has accelerated technology adaptation for patient populations. The conversation delves into the growing collaborations in digital therapeutics and the increasing provider interest in this field. Madleine highlights expanding opportunities for MSLs in tech and the importance of education in this evolving area. The episode concludes with an invitation for audience engagement and a call to subscribe.

Madleine Makori, Sr Medical Science Liaison at Big Health discusses everything you need to know about Digital Therapeutics

Maddy explains…

👉 What is Digital Therapeutics and how it differs from wellness and lifestyle apps

👉 How Digital Therapeutics is making an impact on the pharmaceutical industry

👉 The impact of Covid-19 and the development of the space

👉 What opportunities may emerge and what it means for Medical Affairs

👉 What the future looks like for the Digital Therapeutics space and what people need to know

Click for Source
Digital Therapeutics, Medical Science Liaison, COVID-19 technology adaptation, opportunities in tech for MSLs, future of Digital Therapeutics

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Explore OVN